ANO1 and cancer: Overexpression of ANO1 in gastrointestinal cancer cells inhibits ferroptosis of tumor cells, promotes the recruitment of cancer‐associated fibroblasts (CAFs) by cancer cells, confers resistance to immunotherapy, and thereby affects the therapeutic effect of cancer treatment [9].